| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |